Patent · US Active

Substituted pyrazolo[4,3-b]pyridines and their use as GluN2B receptor modulators

US11161846B2 · kind B2 · utility

2Cited by

13References

26Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Afton Hiscox · Toronto, CA
Brice M. Stenne · Village of La Jolla, US
Christine F. Gelin · San Diego, US
Andrew V. Samant · San Diego, US
Jessica L. Wall · San Diego, US
Michael A. Letavic · San Diego, US
Curt A. Dvorak · Poway, US

Key dates

Filing date	Jun 12, 2020
Grant date	Nov 2, 2021
Priority date	—
Expiry date	Jun 12, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Substituted pyrazolo[4,3-b]pyridines as GluN2B receptor ligands. Such compounds may be used in GluN2B receptor modulation and in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by GluN2B receptor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.